sorbitol has been researched along with Congenital Disorders of Glycosylation in 2 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
Congenital Disorders of Glycosylation: A genetically heterogeneous group of heritable disorders resulting from defects in protein N-glycosylation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epalrestat, an aldose reductase inhibitor increases phosphomannomutase (PMM) enzyme activity in a PMM2-congenital disorders of glycosylation (CDG) worm model." | 4.02 | Sorbitol Is a Severity Biomarker for PMM2-CDG with Therapeutic Implications. ( Brucker, W; Cassiman, D; Edmondson, AC; Garapati, K; Ghesquière, B; Johnsen, C; Kozicz, T; Krzysciak, W; Lam, C; Larson, A; Ligezka, AN; McGovern, RM; Mercimek-Andrews, S; Morava, E; Muthusamy, K; Oglesbee, D; Pandey, A; Perlstein, EO; Preston, G; Radenkovic, S; Ranatunga, W; Raymond, K; Reid, JM; Saraswat, M; Witters, P; Yanaihara, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ligezka, AN | 1 |
| Radenkovic, S | 1 |
| Saraswat, M | 1 |
| Garapati, K | 1 |
| Ranatunga, W | 1 |
| Krzysciak, W | 1 |
| Yanaihara, H | 1 |
| Preston, G | 1 |
| Brucker, W | 1 |
| McGovern, RM | 1 |
| Reid, JM | 1 |
| Cassiman, D | 1 |
| Muthusamy, K | 1 |
| Johnsen, C | 1 |
| Mercimek-Andrews, S | 1 |
| Larson, A | 1 |
| Lam, C | 1 |
| Edmondson, AC | 2 |
| Ghesquière, B | 1 |
| Witters, P | 1 |
| Raymond, K | 1 |
| Oglesbee, D | 1 |
| Pandey, A | 1 |
| Perlstein, EO | 1 |
| Kozicz, T | 1 |
| Morava, E | 1 |
| Hong, X | 1 |
| Strong, A | 1 |
| Pomerantz, D | 1 |
| Michl, E | 1 |
| Berry, G | 1 |
| He, M | 1 |
2 other studies available for sorbitol and Congenital Disorders of Glycosylation
| Article | Year |
|---|---|
Sorbitol Is a Severity Biomarker for PMM2-CDG with Therapeutic Implications.
Topics: Adolescent; Adult; Aged; Biomarkers; Child; Child, Preschool; Congenital Disorders of Glycosylation; | 2021 |
Combined PMM2-CDG and hereditary fructose intolerance in a patient with mild clinical presentation.
Topics: Congenital Disorders of Glycosylation; Fructose; Fructose Intolerance; Humans; Phosphotransferases ( | 2023 |